OPRM1 c.118A>G

OPRM1 c.118A>G

The OPRM1 c.118A>G Novallele Genotyping Assay identifies a single nucleotide change within the mu1 opioid receptor (OPRM1) in association with the 118G allele. Mutations in this gene may cause a downstream effect of reduced opioid drug metabolism. Reduced opioid drug metabolism may play a role in neurological addiction pathways.

£177.00

Get in touch

Get in touch with the team

  • :

Product Description

The OPRM1 c.118A>G Novallele Genotyping Assay is used to amplify and identify specific genetic polymorphisms or mutations. This assay provides scientists with a simple way to quickly genotype this locus from isolated human genomic DNA. The assay contains functionally-verified oligonucleotide primers necessary for PCR and subsequent allele identification by DNA melting. For Research Use Only. Not for use in diagnostic procedures.